IGC
Price
$0.28
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Capitalization
28.8M
67 days until earnings call
Intraday BUY SELL Signals
VIR
Price
$10.62
Change
+$0.04 (+0.38%)
Updated
Sep 11 closing price
Capitalization
1.8B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IGC vs VIR

IGC vs VIR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IGC vs. VIR commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGC is a StrongBuy and VIR is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($1.8B) has a higher market cap than IGC($28.8M). VIR YTD gains are higher at: 76.119 vs. IGC (-0.995). IGC has higher annual earnings (EBITDA): -7.52M vs. VIR (-268.68M). VIR has more cash in the bank: 533M vs. IGC (354K). IGC has less debt than VIR: IGC (1.08M) vs VIR (93.3M). VIR has higher revenues than IGC: VIR (303M) vs IGC (1.11M).
IGCVIRIGC / VIR
Capitalization28.8M1.8B2%
EBITDA-7.52M-268.68M3%
Gain YTD-0.99576.119-1%
P/E RatioN/AN/A-
Revenue1.11M303M0%
Total Cash354K533M0%
Total Debt1.08M93.3M1%
FUNDAMENTALS RATINGS
IGC vs VIR: Fundamental Ratings
IGC
VIR
OUTLOOK RATING
1..100
8988
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
5837
P/E GROWTH RATING
1..100
10023
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IGC's Valuation (38) in the Biotechnology industry is in the same range as VIR (57) in the null industry. This means that IGC’s stock grew similarly to VIR’s over the last 12 months.

IGC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VIR (100) in the null industry. This means that IGC’s stock grew similarly to VIR’s over the last 12 months.

VIR's SMR Rating (96) in the null industry is in the same range as IGC (98) in the Biotechnology industry. This means that VIR’s stock grew similarly to IGC’s over the last 12 months.

VIR's Price Growth Rating (37) in the null industry is in the same range as IGC (58) in the Biotechnology industry. This means that VIR’s stock grew similarly to IGC’s over the last 12 months.

VIR's P/E Growth Rating (23) in the null industry is significantly better than the same rating for IGC (100) in the Biotechnology industry. This means that VIR’s stock grew significantly faster than IGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IGCVIR
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
Bullish Trend 12 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
71%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (IGC: $0.28 vs. VIR: $10.62)
Brand notoriety: IGC and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGC: 57% vs. VIR: 96%
Market capitalization -- IGC: $28.8M vs. VIR: $1.8B
IGC [@Biotechnology] is valued at $28.8M. VIR’s [@Biotechnology] market capitalization is $1.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGC’s FA Score shows that 0 FA rating(s) are green while VIR’s FA Score has 1 green FA rating(s).

  • IGC’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than IGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGC’s TA Score shows that 5 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • IGC’s TA Score: 5 bullish, 5 bearish.
  • VIR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both IGC and VIR are a good buy in the short-term.

Price Growth

IGC (@Biotechnology) experienced а -6.51% price change this week, while VIR (@Biotechnology) price change was -6.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

IGC is expected to report earnings on Nov 18, 2026.

VIR is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IGC
Daily Signal:
Gain/Loss:
VIR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FOSL4.730.24
+5.35%
Fossil Group
QBTS16.800.14
+0.84%
D-Wave Quantum
FMBH51.020.17
+0.33%
First Mid Bancshares
GILD143.72-1.09
-0.75%
Gilead Sciences
GTEC1.05-0.02
-1.87%
Greenland Technologies Holding Corp

IGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGC has been loosely correlated with TECX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IGC jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
-1.55%
TECX - IGC
49%
Loosely correlated
+1.54%
RXRX - IGC
35%
Loosely correlated
+1.27%
VIR - IGC
33%
Loosely correlated
+0.38%
CRBU - IGC
31%
Poorly correlated
-7.30%
ANVS - IGC
30%
Poorly correlated
-5.88%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
+0.38%
BEAM - VIR
54%
Loosely correlated
-1.56%
DNLI - VIR
52%
Loosely correlated
-1.45%
EDIT - VIR
51%
Loosely correlated
+1.89%
RCUS - VIR
50%
Loosely correlated
-5.97%
CRBU - VIR
49%
Loosely correlated
-7.30%
More